NASDAQ : GNTA
Genenta Science S.p.A. — Company profile
Healthcare · Biotechnology · Italy
Last price 0.62 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 29.89M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Genenta Science S.p.A. operates as a strategic consolidator that focuses on acquiring ownership of privately held companies operating in Italian national-security-regulated sectors. Its activities and acquisition strategy covers aerospace, defense, national security, and biotechnology/biosecurity. Genenta Science S.p.A. was incorporated in 2014 and is headquartered in Milan, Italy.
Details
| Name | Genenta Science S.p.A. |
| Sector | Industrials |
| Industry | Conglomerates |
| Employees | 9 |
| Founded | 2014 |
| Ipo Date | 2021-12-15 |
| Ceo | Pierluigi Paracchi |
| Country | Italy |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| Ipo Price | 11.50 |
| Isin | US36870W1009 |
| Cusip | 36870W100 |
| Cik | 1838716 |
| Sic | 2836 |
Key executives
| Name | Title |
|---|---|
| Pierluigi Paracchi | Co-Founder, Chairman, Chief Executive Officer and GM |
| Richard B. Slansky | Chief Financial Officer |
| Gianfranco De Nigris | Vice President of Corporate Development |
| Barbara Regonini | Finance Director |
Contact
| Address | Via dell’Annunciata 31, Milan, Michigan 20121, Italy |
| Phone | 39 02 29 00 10 55 |
| Website | https://www.genenta.com |